By Robert Chase II, Thomas Cullinan, Mary Monahan, Susan Seabrook, Carol Tello and Rich Sun ( October 17, 2017, 3:08 PM EDT) -- On Friday, Sept. 29, 2017, the federal court for the Western District of Texas struck down the temporary anti-inversion regulation issued under Section 7874, which has been charged with preventing the planned $160 billion merger between Pfizer Inc. and Allergan PLC, as well as potentially other cross-border merger transactions involving U.S. corporations. The court held that the temporary regulation was unlawfully implemented as it violated the notice-and-comment procedures under the Administrative Procedures Act (APA). Chamber of Commerce v. Internal Revenue Service, W.D. Tex. No. 16-CV-944 (Sept. 29, 2017)....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.